Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclerion Therapeutics, Inc.

3.70
+0.450013.85%
Pre-market: 3.750.0500+1.35%08:26 EDT
Volume:50.83K
Turnover:175.89K
Market Cap:11.88M
PE:-3.05
High:3.75
Open:3.28
Low:3.14
Close:3.25
Loading ...
May 04, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 14, 2020

Major Issues Report

8-K - Current report
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Dec 27, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 30, 2019

Major Issues Report

Current report, items 2.02, 2.05, 8.01, and 9.01
Sep 25, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 17, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities